Vitrolife AB (publ) hereby invites analysts, investors, shareholders and journalists to a Capital Markets Day on November 21.
We will talk about Vitrolife’s business, which assists in making many people’s desire to have children a reality. We will give an update on the market trends and the strategy together with an update on the operative and financial development. Furthermore, we will present the new partnership with Illumina on preimplantation genetic testing. There will be an opportunity to visit one of our production facilities between approx. 15:30-16:30. The presentations will be held in English.
November 21, at 16:30-18:30
Vitrolife’s headquarters, Gustaf Werners gata 2, 421 32 Västra Frölunda/Gothenburg
Please inform Anita Ahlqvist that you will attend by email, email@example.com, or by telephone on +46 (0)31–721 80 83, no later than November 5. A light meal will be served, so please inform us of any allergies you may have. There is limited seating.
Gothenburg, October 4, 2018
VITROLIFE AB (publ)
For further information, please contact:
Thomas Axelsson, CEO, 46 31 721 80 01
Mikael Engblom, CFO, 46 31 721 80 14
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.